Skip to main content
 

Main menu

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Archives
    • Most-Read Papers of 2022
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2023 Open Forum
    • 2023 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • The Journal

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
American Association for Respiratory Care
  • Subscribe
  • My alerts
  • Log in
American Association for Respiratory Care

Advanced Search

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Archives
    • Most-Read Papers of 2022
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2023 Open Forum
    • 2023 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • The Journal
  • Twitter
  • Facebook
  • YouTube
Review ArticleSystematic Reviews

Peak Oxygen Uptake and Mortality in Cystic Fibrosis: Systematic Review and Meta-Analysis

Fernanda Maria Vendrusculo, João Paulo Heinzmann-Filho, Juliana Severo da Silva, Margarita Perez Ruiz and Márcio Vinícius Fagundes Donadio
Respiratory Care January 2019, 64 (1) 91-98; DOI: https://doi.org/10.4187/respcare.06185
Fernanda Maria Vendrusculo
Laboratory of Pediatric Physical Activity, Centro Infant, Institute of Biomedical Research, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
João Paulo Heinzmann-Filho
Laboratory of Pediatric Physical Activity, Centro Infant, Institute of Biomedical Research, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juliana Severo da Silva
Laboratory of Pediatric Physical Activity, Centro Infant, Institute of Biomedical Research, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margarita Perez Ruiz
School of Doctoral Studies and Research, Universidad Europea de Madrid, Madrid, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Márcio Vinícius Fagundes Donadio
Laboratory of Pediatric Physical Activity, Centro Infant, Institute of Biomedical Research, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Abstract

BACKGROUND: Aerobic fitness, as measured by peak oxygen uptake (V̇O2 peak), correlates with survival in children and adults with cystic fibrosis (CF). We sought to evaluate the effects of V̇O2 peak on mortality rates in subjects with CF.

METHODS: An online search in PubMed, Embase, LILACS, and SciELO databases was conducted, and cohort studies that assessed mortality rates after oxygen absorption measurements during a maximal exercise test were included. Data were extracted independently by 2 reviewers. The quality analysis of the selected articles was performed using the Newcastle-Ottawa scale. The main outcome evaluated was the mortality of subjects with CF. Whenever possible, and if appropriate, a random effect meta-analysis was performed.

RESULTS: Six cohort studies were included in this systematic review including 551 subjects. Five studies were classified with high methodological quality. Two analyses were carried out to evaluate the influence of V̇O2 peak on mortality. Total difference standardized mean between V̇O2 peak averages in the survival or non-survival groups was −0.606 (95% CI = −0.993 to −0.219, P = .002). In addition, subjects with a lower V̇O2 peak had a significantly higher mortality risk (relative risk 4.896, 95% CI = 1.086 to 22.072, P = .039) in an 8-y follow-up period.

CONCLUSION: Low levels of peak oxygen uptake are associated with an increase of 4.9 in the risk of mortality in subjects with CF. This indicates that V̇O2 could be an important follow-up variable to measure, in addition to FEV1.

  • cystic fibrosis
  • oxygen consumption
  • exercise capacity
  • exercise test
  • mortality
  • survival

Introduction

Cystic fibrosis (CF) is a multisystemic genetic disease characterized by progressive loss of lung function and consequent limitation of aerobic fitness.1 Although morbidity and mortality are still a major concern in the disease management, life expectancy is increasing each year with advancement in the diagnosis and treatment; according to data from the Cystic Fibrosis Foundation, the expected median survival in the year 2015 was 41.7 y.2 Thus, as lung function is better maintained and aging of patients increases, other comorbidities rise and there is a growing importance of factors such as the preservation of aerobic fitness status.3

In general, many factors have been associated with a worse prognosis in individuals with CF, among them sex,4 decline in lung function,4–7 number of exacerbations,6,7 nutritional status,7–9 chronic colonization of the airways,10,11 and peak oxygen consumption (V̇O2 peak).5,11,12 It is known that the reduction of V̇O2 peak is of multifactorial origin, given that the mechanisms that can limit aerobic fitness include respiratory, cardiovascular, and of peripheral muscles.13 Therefore, performance on the cardiopulmonary exercise test (CPET) depends on more than lung function and thus reflects the effects of the disease on other organ systems earlier on,14 although FEV1 has still been cited as the best predictor of mortality in children and adults with CF.4,11,12 Thus, considering only lung function as a disease progression marker may not identify other factors that lead to morbidity and mortality in these subjects. Therefore, aerobic fitness evaluation through CPET seems to be a more comprehensive method.15

CPET is considered the gold standard for evaluating aerobic fitness and has been used not only to follow the evolution of the disease,16 because it evaluates the performance and interaction of the cardiovascular, respiratory, and metabolic systems,17 but also for the prescription of physical exercise.18 In addition, studies have shown high reproducibility of CPET for young19 and adult20 subjects with CF, demonstrating a coefficient of variation of 9.3% and 6.9%, respectively. Moreover, the recent statement on exercise testing in CF recommends performing CPET in individuals aged ≥ 10 y as an important part of the annual review process.15

Exercise intolerance due to hyperinflation and increased respiratory work caused by airway obstruction may be present as the disease advances,21 although it is increasingly common to find some pediatric patients who do not present dynamic hyperinflation during exercise. Aerobic fitness correlates with survival in children12 and adults5,11 with CF. Nixon et al11 was the first to demonstrate that V̇O2 peak (< 45 mL/kg/min) could be a predictor of survival in young individuals. A few years later, this finding was replicated by the study of Pianosi et al,12 which showed that subjects with V̇O2 peak > 82% of predicted had a better rate of survival.

Thus, we hypothesized that a low V̇O2 peak was an independent predictor of mortality in individuals with CF. Therefore, we performed a systematic review and quantitative meta-analysis of all available studies that reported the effects of peak oxygen consumption on mortality rates in individuals with CF.

Methods

This systematic review was performed following the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines,22 and data were described according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.23 The protocol of this review was registered in the international prospective register of systematic reviews and was accepted under the number CRD42016045759.

Search Strategy

Studies were identified from the following databases: PubMed, Embase, LILACS, and SciELO. The terms used were (“exercise test” or “exercise testing” or “cardiopulmonary exercise test” or “cardiopulmonary exercise testing” or “peak oxygen uptake” or “maximal oxygen consumption” or “exercise tolerance” or “exercise capacity”) and (“mortality” or “survival”) and (“cystic fibrosis”). No filters were used. A manual search was performed on the bibliographic references of the selected articles to search for additional publications that were pertinent to the study purpose. The searches were conducted in March 2017.

Study Selection

Two authors (FMV and JSdS) independently evaluated article titles and abstracts, thereby selecting the studies to be included in the review. Cohort studies of subjects with CF that assessed mortality rates after oxygen uptake measurements during a maximal exercise test were included. Articles that did not use variables of the maximal exercise test to predict mortality, articles that assessed the mortality of individuals already on the lung transplant list (because the inclusion of severely ill individuals would potentially bias the analysis), review studies, case studies, experimental models, abstracts, response letters, editorials, and duplicate publications, as well as those that did not meet inclusion criteria, were excluded after the analysis of the abstract or full text. Disagreements over the inclusion criteria of a particular study were discussed and resolved through consensus. A third author (MVFD) evaluated and resolved the discrepancies whenever disagreement or doubts between the 2 authors remained.

Data Extraction

The following data were extracted from each of the selected studies: title, first author's name, year of publication, country of origin, language of publication, type of study, age of subjects, sample size, type of equipment used, type of protocol used, duration of follow-up, V̇O2 peak, breathing reserve, ventilatory equivalent for peak oxygen consumption (V̇E/V̇O2), and ventilatory equivalent for carbon dioxide production (V̇E/V̇CO2). In addition, data from the variables of the cardiopulmonary exercise test and other variables that could predict the mortality of CF patients were collected. Any discrepancies were resolved by consensus among the researchers. Moreover, whenever appropriate, an attempt to contact authors of the included studies was performed in order to request additional information.

Quality Analysis

The quality analysis of the selected articles was performed individually by 2 authors (FMV and JPH-F) using the Newcastle-Ottawa Scale, which assigns a maximum of 9 points to the highest quality studies according to the 3 evaluated parameters: selection (4 points), comparability (2 points), and outcome (3 points).24 The overall quality of the study was defined as poor (score 0–3), reasonable (score 4–6), or high (score 7–9). The findings were discussed together with a third author (MVFD), and the discrepancies or doubts were resolved by consensus.

Synthesis of Data and Statistical Analysis

When possible and appropriate, a randomized meta-analysis of the studies was conducted. The standard difference of the V̇O2 peak averages between the survival and non-survival groups was performed by extracting the average data, sample size, and P value from each study included in that analysis. The association of high or low V̇O2 peak with mortality was calculated between the survival and non-survival groups by extracting the relative risk and the 95% CI and/or the number of events (death) and the total of participants in each group, using the DerSimonian-Laird randomized model.

Forest plots with the point size reflecting study weight were used to graphically represent the results of meta-analysis. The I2 and Q tests were used to quantify the degree of heterogeneity between the studies. It was not possible to evaluate the bias of publication with the Egger's test due to the small number of studies included in each analysis. All analysis were performed in the comprehensive meta-analysis software (Biostat, Englewood, New Jersey).

Results

A total of 8,698 articles were found (3,886 in PubMed, 4,787 in EMBASE, and 25 in LILACS). Of these, 2,786 studies were excluded because they were repeated in the database searches, and 5,904 studies were excluded because they did not meet the eligibility criteria of our study. Eight studies were assessed for eligibility, and after analysis of the full text, 2 studies were excluded for including individuals already on a transplant list.25,26 Therefore, 6 studies were included in this review, and 4 studies were included in the meta-analysis. Figure 1 shows the flow chart of the articles found and the reasons for the exclusion of studies.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Flow chart. CPET = cardiopulmonary exercise testing; CF = cystic fibrosis.

The selected articles included a total of 551 subjects, and the sample size of each study varied between 28 and 149 subjects, with ages ranging from 10 to 30.2 y and follow-up time between 2.8 and 8 y (Table 1). Only 2 studies presented CFTR genotype classification, although no separate analyses were performed.9,10 All studies used the cycle ergometer to perform CPET. However, when evaluating the type of protocol, 3 studies used the Godfrey protocol,9–11 2 performed a ramp protocol,5,27 and 1 study12 used a step increment. The V̇O2 peak, breathing reserve, V̇E/V̇O2, and V̇E/V̇CO2 data from each article are presented in Table 2.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Main Methodological Characteristics of the Studies

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2.

Main Results of Cardiopulmonary Exercise Test Variables of the Studies Included in the Systematic Review

Regarding the overall methodological quality, 5 of the included studies5,9,11,12,27 were classified as high quality, and two5,11 of these received the maximum score (9 points). On the other hand, only 1 article10 was classified as reasonable quality and was assigned 6 points. Table 3 presents the parameters evaluated in the Newcastle-Ottawa Scale.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3.

Newcastle-Ottawa Scale: Methodological Quality of Cohort Studies Included in the Systematic Review

Table 4 shows the data of significant variables to predict mortality in CF subjects. V̇O2 peak was significant in 5 studies,5,9–12 and breathing reserve was significant in 1 study.9 In the study by Nguyen et al,27 only the arterial-alveolar oxygen gradient was significant. With regard to other variables, FEV1 was significant in 5 studies,5,9,11,12,27 body mass index (BMI) was significant in 2 studies,9,27 and Pseudomonas cepacia colonization was significant in 1 study.11 To determine the influence of CPET variables on the mortality of subjects with CF, 3 studies9,11,12 used Cox proportional hazards, whereas the other 3 studies used log rank tests,10 multivariate logistic regression,27 and chi-square tests.5

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 4.

Variables Used as Mortality Predictors in Patients with Cystic Fibrosis

Meta-analysis

Two different analyses were carried out to evaluate the influence of V̇O2 peak on mortality in subjects with CF, and 2 studies were included in each analysis. Figure 2A shows data from articles reporting differences between averages of V̇O2 peak in the survival and non-survival groups. The I2 analysis did not show heterogeneity between studies (I2 = 0%, P = .84). The total difference standardized mean was −0.606 (CI 95% = −0.993 to −0.219, P = .002), indicating that subjects in the non-survival group had a lower V̇O2 peak compared to survivors.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Meta-analysis of studies that reported mean difference in V̇O2 peak between survival or non-survival groups (A) and the association (relative risk, 95% CI) of V̇O2 peak (high vs. low–moderate) with mortality (B). Low V̇O2 peak was considered when < 45 mL/kg/min or 82% of predicted.

Subjects with a lower V̇O2 peak (< 45 mL/kg/min or < 82% of predicted) were associated with a significantly higher risk for mortality (relative risk 4.896, 95% CI = 1.086 to 22.072, P = .039). There was a small but not significant heterogeneity in the studies (I2 = 31.56%, P = .23) included in this analysis (Fig. 2B). It was not possible to generate funnel charts in the analysis because of the small number of studies included.

Discussion

Low aerobic fitness has been reported in individuals with CF and is associated with several factors, including impairment of lung function,28 poor nutritional status,29 low muscle power,28 cardiac dysfunction,30 high level of inflammation,10 and physical deconditioning.28 V̇O2 peak, defined as the peak amount of oxygen that can be transferred and utilized during exercise, is the main parameter in the evaluation of aerobic capacity.18 Our systematic review and meta-analyses demonstrate that subjects with lower V̇O2 peak rates (ie, values < 82% of predicted or 45 mL/kg/min) demonstrated a 4.9-fold increased risk for a fatal outcome, indicating that measurement of aerobic fitness could be a tool for prognosis in patients with CF. Furthermore, the difference between means indicated that subjects in the non-survival group had a lower V̇O2 peak compared to the survivors. This association of oxygen consumption with mortality has also been described for individuals with COPD31,32 and chronic heart failure.33,34 To our knowledge, this is the first meta-analysis to evaluate the association of V̇O2 peak with mortality in subjects with CF.

Nguyen et al27 was the only study included that found no relationship between V̇O2 peak and mortality. They demonstrated only that alveolar-arterial gradient for oxygen at peak exercise was significantly associated with mortality. On the other hand, the remaining articles demonstrated an association between V̇O2 peak and mortality. However, other variables, including FEV1 and BMI, were also significant in predicting mortality. A higher BMI has been associated with an increased likelihood of survival in subjects with CF,7–9,35 corroborating the results from Nguyen et al27 and Hulzebos et al.9 Furthermore, FEV1 has been considered the best predictor of mortality in subjects with CF,4,11,12 including those on lung transplant lists.36 According to Kerem et al4 individuals with FEV1 < 30% of predicted should be referred for lung transplantation. Moorcroft et al5 showed that, despite the correlation of V̇O2 peak with survival, FEV1 is still the best indicator of prognosis. On the other hand, Rosenthal37 described that lung function between 8 y and 12 y was a poor indicator of the risk of dying or being transplanted. Moreover, Pianosi et al12 demonstrated that the change in V̇O2 peak over time is more useful as a prognostic marker than the commonly used longitudinal decline in FEV1. In addition, abnormalities in aerobic fitness in early disease in stable subjects may reflect changes that are not detected with spirometry, given that Dodd et al38 have demonstrated that the correlation between thoracic computed tomography abnormalities and exercise limitation is stronger than the correlation between spirometry and BMI with exercise limitation. Thus, it is possible that V̇O2 peak is a better prognostic marker early in life than FEV1, considering that CPET is dependent on more than lung function and thus reflects the effects of the disease on other organ systems earlier on; however, further studies are needed to directly address this question.

Information obtained through CPET plays an important role in the care and follow-up of patients with CF because of its contribution to prognosis and functional information.18 Thus, an annual follow-up of V̇O2 peak is relevant to identify individuals at risk for a worsening prognosis,15 as well as those who may benefit from more intense therapy,39 considering that aerobic fitness correlates with survival in children12 and adults5,11 with CF. In addition, it is well-established that exercise increases V̇O2 peak, indicating its importance as a therapeutic tool that could influence prognosis.40

The studies included in this systematic review and meta-analysis showed variation in follow-up time, ranging from 2.8 y to 8 y. Considering that these are studies to evaluate mortality, a short follow-up time may be considered as a limitation because it could influence this outcome. In addition, it is already known that the evolution of CF is characterized by a decline in lung function and exercise limitation,1 highlighting the role of long-term follow-up periods in the evaluation of mortality rates.

As for the reported variables of CPET, the included studies showed a large variability, which prevented us from including some articles in certain analyses and to evaluate the influence of other variables such as ventilatory reserve data, V̇E/V̇O2, and V̇E/V̇CO2. A high breathing reserve index at the lactate threshold represents a reduction of pulmonary mechanical reserve and was already reported as a predictor of mortality in individuals with CF waiting for lung transplantation.25 In addition, V̇E/V̇O2 measurement has also been shown to be important in predicting mortality.5,9 Despite the relevance of the analyzed variables, it is important to recognize that CPET is not widely available in CF centers and requires specific equipment and expert personnel to perform and interpret the test. On the other hand, increasing life expectancy and new therapeutic options are changing the clinical presentation of CF, and markers such as lung function are better maintained over time, highlighting the importance of other factors such as aerobic fitness. Thus, studies designed to evaluate the prognostic value of CPET as compared to nutritional status, lung function, and other exercise tests are needed to further understand the role of aerobic fitness as a disease progression marker in CF.

Regarding the methodological quality of the studies included, in general, a high quality was found because only 1 study10 presented a reasonable classification according to the Newcastle-Ottawa Scale, which strengthens our systematic review and meta-analysis. In addition, the I2 test in the analysis of the difference between means did not show heterogeneity, and the relative risk analysis showed a low heterogeneity among the included studies, which may confirm the power of the analysis presented, despite the small number of articles.

One of the main limitations of this study is the small number of articles included in each analysis and the variability of the parameters evaluated. Due to the different presentations of data, only 2 articles were included in each of the analyses. Therefore, it was not possible to perform a funnel chart to evaluate publication bias of the studies. A short follow-up period, especially for a population of young children and adolescents, may also be considered a limitation in the evaluation of mortality. Two studies9,10 included subjects from the same CF center and with similar characteristics, which may include some shared members of a cohort. In addition, the lack of response when we tried to contact the authors of some of the studies9–12 to request additional V̇O2 peak information distinguished between survivors and non-survivors may be considered a limitation of present study.

Conclusions

This systematic review and meta-analysis showed that a low level of peak oxygen uptake is associated with higher mortality in CF, as subjects with reduced V̇O2 peak had a 4.9-fold increased risk for a fatal outcome. This indicates that V̇O2 peak may be an important follow-up variable to measure in addition to FEV1, although data from our analyses should be interpreted with caution due to the small number of studies included. Moreover, comparisons between aerobic capacity variables, FEV1, and BMI as mortality predictors in CF need to be further explored in future studies.

Footnotes

  • Correspondence: Márcio Donadio, Laboratory of Pediatric Physical Activity, Centro Infant, Institute of Biomedical Research, Av. Ipiranga, 6690, 2° andar, Porto Alegre, Rio Grande do Sul, CEP 90610-000, Brazil. E-mail: mdonadio{at}pucrs.br
  • The authors have disclosed no conflicts of interest.

  • Copyright © 2019 by Daedalus Enterprises

References

  1. 1.↵
    1. Gibson RL,
    2. Burns JL,
    3. Ramsey BW
    . Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168(8):918–951.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Cystic Fibrosis Foundation Patient Registry, 2015 Annual Data Report. Available at https://www.cff.org/Our-Research/CF-Patient-Registry/2015-Patient-Registry-Annual-Data-Report.pdf Accessed Feb 20, 2017.
  3. 3.↵
    1. Currie S,
    2. Greenwood K,
    3. Weber L,
    4. Khakee H,
    5. Legasto M,
    6. Tullis E,
    7. et al
    . Physical activity levels in individuals with cystic fibrosis-related diabetes. Physiother Can 2017;69(2):171–177.
    OpenUrl
  4. 4.↵
    1. Kerem E,
    2. Reisman J,
    3. Corey M,
    4. Canny GJ,
    5. Levison H
    . Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326(18):1187–1191.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Moorcroft AJ,
    2. Dodd ME,
    3. Webb AK
    . Exercise testing and prognosis in adult cystic fibrosis. Thorax 1997;52(3):291–293.
    OpenUrlAbstract
  6. 6.↵
    1. Buzzetti R,
    2. Alicandro G,
    3. Minicucci L,
    4. Notarnicola S,
    5. Furnari ML,
    6. Giordano G,
    7. et al
    . Validation of a predictive survival model in Italian patients with cystic fibrosis. J Cyst Fibros 2012;11(1):24–29.
    OpenUrlPubMed
  7. 7.↵
    1. Liou TG,
    2. Adler FR,
    3. FitzSimmons SC,
    4. Cahill BC,
    5. Hibbs JR,
    6. Marshall BC
    . Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001;153(4):345–352.
    OpenUrlCrossRefPubMed
  8. 8.
    1. Fogarty AW,
    2. Britton J,
    3. Clayton A,
    4. Smyth AR
    . Are measures of body habitus associated with mortality in cystic fibrosis? Chest 2012;142(3):712–717.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Hulzebos EH,
    2. Bomhof-Roordink H,
    3. van de Weert-van Leeuwen PB,
    4. Twisk JW,
    5. Arets HG,
    6. van der Ent CK,
    7. Takken T
    . Prediction of mortality in adolescents with cystic fibrosis. Med Sci Sports Exerc 2014;46(11):2047–2052.
    OpenUrlCrossRef
  10. 10.↵
    1. Van de Weert-van Leeuwen P,
    2. Slieker M,
    3. Hulzebos H,
    4. Kruitwagen C,
    5. van der Ent C,
    6. Arets H
    . Chronic infection and inflammation affect exercise capacity in cystic fibrosis. Eur Respir J 2012;39(4):893–898.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Nixon PA,
    2. Orenstein DM,
    3. Kelsey SF,
    4. Doershuk CF
    . The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992;327(25):1785–1788.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Pianosi P,
    2. Leblanc J,
    3. Almudevar A
    . Peak oxygen uptake and mortality in children with cystic fibrosis. Thorax 2005;60(1):50–54.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Troosters T,
    2. Langer D,
    3. Vrijsen B,
    4. Segers J,
    5. Wouters K,
    6. Janssens W,
    7. et al
    . Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J 2009;33(1):99–106.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    American Thoracic Society. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167(2):211–217.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Hebestreit H,
    2. Arets HG,
    3. Aurora P,
    4. Boas S,
    5. Cerny F,
    6. Hulzebos EH,
    7. et al
    . Statement on exercise testing in cystic fibrosis. Respiration 2015;90(4):332–351.
    OpenUrl
  16. 16.↵
    1. Pianosi P,
    2. LeBlanc J,
    3. Almudevar A
    . Relationship between FEV1 and peak oxygen uptake in children with cystic fibrosis. Pediatr Pulmonol 2005;40(4):324–329.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Savi D,
    2. Di Paolo M,
    3. Simmonds N,
    4. Onorati P,
    5. Internullo M,
    6. Quattrucci S,
    7. et al
    . Relationship between daily physical activity and aerobic fitness in adults with cystic fibrosis. BMC Pulm Med 2015;15(1):59.
    OpenUrl
  18. 18.↵
    1. Ferrazza A,
    2. Martolini D,
    3. Valli G,
    4. Palange P
    . Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration 2009;77(1):3–17.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Saynor ZL,
    2. Barker AR,
    3. Oades PJ,
    4. Williams CA
    . Reproducibility of maximal cardiopulmonary exercise testing for young cystic fibrosis patients. J Cyst Fibros 2013;12(6):644–650.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. McKone E,
    2. Barry S,
    3. FitzGerald M,
    4. Gallagher C
    . Reproducibility of maximal exercise ergometer testing in patients with cystic fibrosis. Chest 1999;116(2):363–368.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. De Jong W,
    2. Van Der Schans C,
    3. Mannes G,
    4. Van Aalderen W,
    5. Grevink R,
    6. Koeter G
    . Relationship between dyspnoea, pulmonry function and exercise capacity in patients with cystic fibrosis. Respir Med 1997;91(1):41–46.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Stroup DF,
    2. Berlin JA,
    3. Morton SC,
    4. Olkin I,
    5. Williamson GD,
    6. Rennie D,
    7. et al
    . Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;283(15):2008–2012.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Liberati A,
    2. Altman DG,
    3. Tetzlaff J,
    4. Mulrow C,
    5. Gøtzsche PC,
    6. Ioannidis JP,
    7. et al
    . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151(4):65–94.
    OpenUrl
  24. 24.↵
    1. Wells G,
    2. Shea B,
    3. O'Connell D,
    4. Peterson J,
    5. Welch V,
    6. Losos M,
    7. et al
    . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at http//www.ohri.ca/programs/clinical_epidemiology/oxford.asp Accessed Mar 27, 2017.
  25. 25.↵
    1. Tantisira KG,
    2. Systrom DM,
    3. Ginns LC
    . An elevated breathing reserve index at the lactate threshold is a predictor of mortality in patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2002;165(12):1629–1633.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Stanchina ML,
    2. Tantisira KG,
    3. Aquino SL,
    4. Wain JC,
    5. Ginns LC
    . Association of lung perfusion disparity and mortality in patients with cystic fibrosis awaiting lung transplantation. J Heart Lung Transplant 2002;21(2):217–225.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Nguyen S,
    2. Leroy S,
    3. Cracowski C,
    4. Perez T,
    5. Valette M,
    6. Neviere R,
    7. et al
    . [Prognostic value of clinical exercise testing in adult patients with cystic fibrosis]. Rev Mal Respir 2010;27(3):219–225.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Hebestreit H,
    2. Kieser S,
    3. Rüdiger S,
    4. Schenk T,
    5. Junge S,
    6. Hebestreit A,
    7. et al
    . Physical activity is independently related to aerobic capacity in cystic fibrosis. Eur Respir J 2006;28(4):734–739.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Klijn PH,
    2. van der Net J,
    3. Kimpen JL,
    4. Helders PJ,
    5. Van der Ent CK
    . Longitudinal determinants of peak aerobic performance in children with cystic fibrosis. Chest 2003;124(6):2215–2219.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Pianosi P,
    2. Pelech A
    . Stroke volume during exercise in cystic fibrosis. Am J Respir Crit Care Med 1996;153(3):1105–1109.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Oga T,
    2. Nishimura K,
    3. Tsukino M,
    4. Sato S,
    5. Hajiro T
    . Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003;167(4):544–549.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Celli BR
    . Predictors of mortality in COPD. Respir Med 2010;104(6):773–779.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Ingle L,
    2. Witte KK,
    3. Cleland JG,
    4. Clark AL
    . Combining the ventilatory response to exercise and peak oxygen consumption is no better than peak oxygen consumption alone in predicting mortality in chronic heart failure. Eur J Heart Fail 2008;10(1):85–88.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Cicoira M,
    2. Davos CH,
    3. Francis DP,
    4. Doehner W,
    5. Zanolla L,
    6. Franceschini L,
    7. et al
    . Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. J Card Fail 2004;10(5):421–426.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Simmonds NJ,
    2. MacNeill SJ,
    3. Cullinan P,
    4. Hodson ME
    . Cystic fibrosis and survival to 40 years: a case–control study. Eur Respir J 2010;36(6):1277–1283.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Belkin RA,
    2. Henig NR,
    3. Singer LG,
    4. Chaparro C,
    5. Rubenstein RC,
    6. Xie SX,
    7. et al
    . Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2006;173(6):659–666.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Rosenthal M
    . Annual assessment spirometry, plethysmography, and gas transfer in cystic fibrosis: do they predict death or transplantation. Pediatr Pulmonol 2008;43(10):945–952.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Dodd JD,
    2. Barry SC,
    3. Barry RB,
    4. Gallagher CG,
    5. Skehan SJ,
    6. Masterson JB
    . Thin-section CT in patients with cystic fibrosis: correlation with peak exercise capacity and body mass index 1. Radiology 2006;240(1):236–245.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Javadpour S,
    2. Selvadurai H,
    3. Wilkes D,
    4. Schneiderman-Walker J,
    5. Coates A
    . Does carbon dioxide retention during exercise predict a more rapid decline in FEV1 in cystic fibrosis? Arch Dis Child 2005;90(8):792–795.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Sosa ES,
    2. Groeneveld IF,
    3. Gonzalez-Saiz L,
    4. Lopez-Mojares LM,
    5. Villa-Asensi JR,
    6. Gonzalez MIB,
    7. et al
    . Intrahospital weight and aerobic training in children with cystic fibrosis: a randomized controlled trial. Med Sci Sports Exerc 2012;44(1):2–11.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Respiratory Care: 64 (1)
Respiratory Care
Vol. 64, Issue 1
1 Jan 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author

 

Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Association for Respiratory Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Peak Oxygen Uptake and Mortality in Cystic Fibrosis: Systematic Review and Meta-Analysis
(Your Name) has sent you a message from American Association for Respiratory Care
(Your Name) thought you would like to see the American Association for Respiratory Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Peak Oxygen Uptake and Mortality in Cystic Fibrosis: Systematic Review and Meta-Analysis
Fernanda Maria Vendrusculo, João Paulo Heinzmann-Filho, Juliana Severo da Silva, Margarita Perez Ruiz, Márcio Vinícius Fagundes Donadio
Respiratory Care Jan 2019, 64 (1) 91-98; DOI: 10.4187/respcare.06185

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Peak Oxygen Uptake and Mortality in Cystic Fibrosis: Systematic Review and Meta-Analysis
Fernanda Maria Vendrusculo, João Paulo Heinzmann-Filho, Juliana Severo da Silva, Margarita Perez Ruiz, Márcio Vinícius Fagundes Donadio
Respiratory Care Jan 2019, 64 (1) 91-98; DOI: 10.4187/respcare.06185
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Keywords

  • cystic fibrosis
  • oxygen consumption
  • exercise capacity
  • exercise test
  • Mortality
  • survival

Info For

  • Subscribers
  • Institutions
  • Advertisers

About Us

  • About the Journal
  • Editorial Board

AARC

  • Membership
  • Meetings
  • Clinical Practice Guidelines

More

  • Contact Us
  • RSS
American Association for Respiratory Care

Print ISSN: 0020-1324        Online ISSN: 1943-3654

© Daedalus Enterprises, Inc.

Powered by HighWire